Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Cancer
|
April 22, 2005
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
Ellen V Stevens, Mark Raffeld, Virginia Espina, et al.
Gynecologic Oncology
|
February 27, 2013
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
Helene Tuft Stavnes, Arild Holth, Trinh Don, et al.
American Journal of Clinical Pathology
|
April 15, 2006
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
Hiep Phuc Dong, Mari Bunkholt Elstrand, Arild Holth, et al.
Clinical & Experimental Metastasis
|
December 13, 2003
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
Ben Davidson, Vered Givant-Horwitz, Philip Lazarovici, et al.
Human Pathology
|
January 23, 2009
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
Lilach Kleinberg, Hiep Phuc Dong, Arild Holth, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 1, 1994
Fifty:fifty poly (DL glycolic acid-lactic acid) copolymer as a drug delivery system for 5-fluorouracil: a histopathological evaluation
L Gould, G Trope, Y L Cheng, et al.
Cancer
|
May 13, 2004
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Ben Davidson, Emilyn Alejandro, Vivi Ann Flørenes, et al.
Human Pathology
|
May 21, 2009
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Yuan Yuan, Dag André Nymoen, Hiep Phuc Dong, et al.
Gynecologic Oncology
|
December 14, 2004
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Ben Davidson, Mari Bukholt Elstrand, Michael T McMaster, et al.
Journal of Translational Medicine
|
February 27, 2010
Genomic aberrations in borderline ovarian tumors
Francesca Micci, Lisbeth Haugom, Terje Ahlquist, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Cancer
|
April 22, 2005
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
Ellen V Stevens, Mark Raffeld, Virginia Espina, et al.
Gynecologic Oncology
|
February 27, 2013
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
Helene Tuft Stavnes, Arild Holth, Trinh Don, et al.
American Journal of Clinical Pathology
|
April 15, 2006
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
Hiep Phuc Dong, Mari Bunkholt Elstrand, Arild Holth, et al.
Clinical & Experimental Metastasis
|
December 13, 2003
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
Ben Davidson, Vered Givant-Horwitz, Philip Lazarovici, et al.
Human Pathology
|
January 23, 2009
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
Lilach Kleinberg, Hiep Phuc Dong, Arild Holth, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 1, 1994
Fifty:fifty poly (DL glycolic acid-lactic acid) copolymer as a drug delivery system for 5-fluorouracil: a histopathological evaluation
L Gould, G Trope, Y L Cheng, et al.
Cancer
|
May 13, 2004
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Ben Davidson, Emilyn Alejandro, Vivi Ann Flørenes, et al.
Human Pathology
|
May 21, 2009
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Yuan Yuan, Dag André Nymoen, Hiep Phuc Dong, et al.
Gynecologic Oncology
|
December 14, 2004
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Ben Davidson, Mari Bukholt Elstrand, Michael T McMaster, et al.
Journal of Translational Medicine
|
February 27, 2010
Genomic aberrations in borderline ovarian tumors
Francesca Micci, Lisbeth Haugom, Terje Ahlquist, et al.
Page
of 8